Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.

A M Lefer, R Scalia, D J Lefer

Journal: Cardiovascular research 2001;49(2):281-7

PMID: 11164838

Full Text on Silverchair Information Systems View on PubMed

Abstract

Address: Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA. [email protected]

DOI: 10.1016/s0008-6363(00)00247-9

Link outs

Free resources

Medical:

https://medlineplus.gov/cholesterolmedicines.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

https://academic.oup.com/cardiovascres/article-loo...

MeSH Terms: Cardiovascular Diseases, Coronary Vessels, Endothelin-1, Endothelins, Endothelium, Vascular, Fibrinolytic Agents, Free Radical Scavengers, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Lovastatin, Muscle, Smooth, Vascular, Neutrophil Infiltration, Nitric Oxide, Nitric Oxide Synthase, Nitric Oxide Synthase Type III, Protein Precursors, Simvastatin

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.